Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular edema ...

Macular degeneration is a prevalent eye disorder that typically results in loss of vision in individuals who are 50 years of age and older. Although there isn’t a recognized cure for this ...

A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...

Discover how a new eye drop treatment may prevent the loss of vision associated with dry age-related macular degeneration, ...

People who develop macular degeneration often begin experiencing symptoms after 50 years old, but symptoms can happen earlier or later depending on conditions and risk factors. Share on Pinterest ...

Investigators conducted a meta-analysis of randomized controlled trials to assess the efficacy and safety of brolucizumab ...

Age-related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal ...

Many people consider the symptoms of aging and blurred vision as a simple presbyopia. However, this may be an early symptom ...

The research team led by Dr. Moon-Hyeong Seo from the Natural Product Drug Development Center at the Korea Institute of ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...